category: News

Novo Nordisk AS (NYSE:NVO) and Hims & Hers Health Inc. (NYSE:HIMS) have reportedly ended their public feud, with…

Over the weekend, SpaceX CEO Elon Musk reacted to comments from former Google CEO Eric Schmidt, who warned…

Oracle Corp (NYSE:ORCL) has teamed up with several Canadian healthcare organizations on Wednesday, with Lumeo Regional Health Information…

Novo Nordisk A/S (NYSE:NVO) is accused of unlawfully extending its monopoly over its diabetes drug Victoza through a…

With health insurer UnitedHealth Group Inc. (NYSE:UNH) set to report its fourth-quarter results on Tuesday, investors remain focused…

Nvidia Corp. (NASDAQ:NVDA) recently stopped testing whether it would manufacture its advanced artificial intelligence chips using Intel Corp.’s…

Last Thursday, President Donald Trump signed the “Ensuring American Space Superiority” executive order aimed at cementing U.S. dominance…

Fox News host Jessica Tarlov pulled no punches when talking about President Donald Trump’s handling of the economy.…

The AI infrastructure build-out has not yet peaked. In fact, AI cap ex spending is accelerating, said Ben…

Elon Musk, CEO of Tesla Inc. (NASDAQ:TSLA), has predicted that the company’s humanoid robot Optimus could revolutionize the…

With Tesla Inc. (NASDAQ:TSLA) expected to release its third-quarter results on Wednesday after markets close, leading analysts are…

As of Oct. 6, 2025, two stocks in the information technology could be flashing a real warning to…

Novo Nordisk And Hims & Hers End Bitter Legal Feud With Surprise Weight-Loss Drug Deal: Report – Hims & Hers Health (NYSE:HIMS), Eli Lilly (NYSE:LLY)